Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia
Arthritis, capsular inflammation, and referred pain patterns from facet dysfunction commonly contribute to lower back symptoms
Aziz Pirani, MD, and Dr
The following framework draws on copper metabolism principles from the American Association for the Study of Liver Diseases (AASLD) Wilson disease guidelines [13] and general wound-care monitoring standards from the Wound Healing Society [14]
US$ 23.42
US$ 25.52
